ePrivacy and GPDR Cookie Consent by TermsFeed Generator

BLENREP

100MG INF PLV CSL 1

SÚKL code 0249884
Name of the product BLENREP
_MA_MEDICATION_DETAIL_INFO_MED_NAME i BLENREP
Supplement 100MG INF PLV CSL 1
Strenght 100MG
Pharmaceutical form Powder for concentrate for solution for infusion
Package 1
Route Intravenous use
Wrap type Vial
Legal status na lékařský předpis
Active substance BELANTAMAB MAFODOTIN (BELANTAMABUM MAFODOTINUM)
ATC group L01FX15
ATC group name BELANTAMAB MAFODOTIN

Marketing authorisation information

Registration Number EU/1/20/1474/001
Type of MA Orphan medicinal products
MA status R - active MA/authorised medicinal product
MA Holder GlaxoSmithKline (Ireland) Limited, Dublin
MA Holder country IRSKO

Back to list